Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v4-FR | Version v2-FR | |
---|---|---|
Language | French | French |
Date Updated | 2017-03-14 | 2017-03-13 |
Drug Identification Number | 00038121 | 00038121 |
Brand name | EPHEDRINE SULFATE INJECTION | EPHEDRINE SULFATE INJECTION |
Common or Proper name | Ephedrine | Ephedrine |
Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
Ingredients | EPHEDRINE SULFATE | EPHEDRINE SULFATE |
Strength(s) | 50MG | 50MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS | INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | 50mg/1mL x 50 | 50mg/1mL x 50 |
ATC code | R03CA | R03CA |
ATC description | ADRENERGICS FOR SYSTEMIC USE | ADRENERGICS FOR SYSTEMIC USE |
Reason for shortage | Shortage of an active ingredient. | Other (Please describe in comments) |
Anticipated start date | ||
Actual start date | 2015-07-24 | 2015-07-24 |
Estimated end date | Unknown | Unknown |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Product Distribution on Hold | Product Distribution on Hold |
Health Canada comments |